DYRK1A and Cognitive impairment: In this context, we hypothesized that change in the dosage of Dyrk1a in glutamatergic neurons of the hippocampus and cortex of DS and MRD7 mouse models somehow alter their development and/or normal working in adult brain, leading to the cognitive deficits observed in DS or Dyrk1a haploinsufficiency models.